FIELD: medicine.
SUBSTANCE: method involves intravenously administering Photoditasin at a dose of 1 mg/kg 2-3 hours before operation. Catheter is introduced into urinary bladder with spherical and cylindrical balloons, the first one being filled with a liquid and pulled toward urinary bladder cervix, the second one, having fiber optic fibers with fiber optic fiber placed in it and provided with cylindrical diffuser, is also filled with liquid and placed in prostatic region of urethra and irradiated with diode laser having specific capacity of 200 mW/cm2 with specific light energy doze being equal to 150-300 J/cm2 during 12,5-25 min.
EFFECT: enabled hyperplastic tissue photodestruction eliminating infravesical obstruction; improved urodynamic properties; improved patient life quality.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREVENTING INJURY TO THE EXTERNAL URETHRAL SPHINCTER WHEN PERFORMING TRANSURETHRAL LASER ENUCLEATION OF BENIGN PROSTATIC HYPERPLASIA | 2021 |
|
RU2757678C1 |
| METHOD OF FRACTIONATED PHOTODYNAMIC THERAPY OF BENIGN PROSTATE HYPERPLASIA | 2008 |
|
RU2367487C1 |
| METHOD FOR TREATING PATIENTS SUFFERING FROM BENIGN HYPERPLASIA OF THE PROSTATE | 2003 |
|
RU2250748C2 |
| METHOD FOR VISUALIZING EFFICIENCY OF TREATMENT OF BENIGN PROSTATIC HYPERPLASIA | 2018 |
|
RU2681508C1 |
| METHOD OF PROVIDING ACCESS TO A SURGICAL OBJECT WHEN PERFORMING PLASMA TRANSURETHRAL ENUCLEATION OF BENIGN PROSTATIC HYPERPLASIA | 2019 |
|
RU2700488C1 |
| METHOD FOR TRANSURETHRAL TREATMENT OF BENIGN PROSTATIC HYPERPLASIA | 2004 |
|
RU2278635C1 |
| METHOD FOR RETROPUBIC ADENOMECTOMY WITH CORRUGATED PLASTY OF PROSTATE CAPSULE | 2023 |
|
RU2795547C1 |
| METHOD FOR INTERMITTENT THERAPY IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA | 2013 |
|
RU2531944C1 |
| METHOD OF NOT-INVASIVE TREATMENT OF NODOSE HYPERPLASY OF PROSTATE | 2005 |
|
RU2283143C1 |
| LAPAROSCOPIC RETROPUBIC ADENOMECTOMY SUPPLEMENTED BY URETHROCYSTOANASTOMOSIS | 2022 |
|
RU2784180C2 |
